Magazine Article | October 7, 2010

Quick Response Manufacturing: Taking The Pharmaceutical Industry Beyond Lean Six Sigma

Source: Life Science Leader

By Ananth Krishnamurthy and Gerald Finken

Pharmaceutical and biotech industries are under enormous pressure to improve quality, increase efficiency, and cut costs of their preclinical research and clinical development processes. However, the manufacturing of APIs and investigational medicinal products (IMPs) and the preparation of clinical supplies in the pharmaceutical and biotech industries present significant challenges in terms of finalizing the process designs, establishing and maintaining cGMP to meet FDA regulations, and optimizing processes for commercial scale production.

Used with permission from Life Science Leader magazine.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: